Company profile ATNM
After 39 days of this quarter the interest is at 17.0. Based on that we can calculate that during remaining 52 days it will total up to 40.0. Actinium Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-73.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 93 | 100 7.5% QoQ | 76 -24.0% QoQ | 91 19.7% QoQ |
| 2020 | 125 34.4% YoY 37.4% QoQ | 368 268.0% YoY 194.4% QoQ | 519 582.9% YoY 41.0% QoQ | 126 38.5% YoY -75.7% QoQ |
| 2021 | 64 -48.8% YoY -49.2% QoQ | 109 -70.4% YoY 70.3% QoQ | 49 -90.6% YoY -55.0% QoQ | 73 -42.1% YoY 49.0% QoQ |
| 2022 | 41 -35.9% YoY -43.8% QoQ | 75 -31.2% YoY 82.9% QoQ | 41 -16.3% YoY -45.3% QoQ | 67 -8.2% YoY 63.4% QoQ |
| 2023 | 151 268.3% YoY 125.4% QoQ | 80 6.7% YoY -47.0% QoQ | 116 182.9% YoY 45.0% QoQ | 41 -38.8% YoY -64.7% QoQ |
| 2024 | 17 -88.7% YoY -58.5% QoQ | - | - | - |
The average 5 years interest of Actinium Pharmaceuticals was 9.28 per week. The last year interest of Actinium Pharmaceuticals compared to the last 5 years has changed by -29.74%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -18.7%.
There is not enough data for Actinium Pharmaceuticals cancer treatment to provide analysis
There is not enough data for Actinium Pharmaceuticals cancer treatment to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals cancer treatment to provide analysis
There is not enough data for Actinium Pharmaceuticals Iomab-B to provide analysis
There is not enough data for Actinium Pharmaceuticals Iomab-B to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals Iomab-B to provide analysis
There is not enough data for Actinium Pharmaceuticals targeted radiotherapies to provide analysis
There is not enough data for Actinium Pharmaceuticals targeted radiotherapies to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals targeted radiotherapies to provide analysis
There is not enough data for Actinium Pharmaceuticals clinical trials to provide analysis
There is not enough data for Actinium Pharmaceuticals clinical trials to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals clinical trials to provide analysis
After 39 days of this quarter the interest is at 20.0. Based on that we can calculate that during remaining 52 days it will total up to 47.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 73 | 126 72.6% QoQ | 99 -21.4% QoQ | 69 -30.3% QoQ |
| 2020 | 118 61.6% YoY 71.0% QoQ | 326 158.7% YoY 176.3% QoQ | 539 444.4% YoY 65.3% QoQ | 137 98.6% YoY -74.6% QoQ |
| 2021 | 72 -39.0% YoY -47.4% QoQ | 87 -73.3% YoY 20.8% QoQ | 34 -93.7% YoY -60.9% QoQ | 119 -13.1% YoY 250.0% QoQ |
| 2022 | 17 -76.4% YoY -85.7% QoQ | 41 -52.9% YoY 141.2% QoQ | 38 11.8% YoY -7.3% QoQ | 106 -10.9% YoY 178.9% QoQ |
| 2023 | 78 358.8% YoY -26.4% QoQ | 18 -56.1% YoY -76.9% QoQ | 65 71.1% YoY 261.1% QoQ | 51 -51.9% YoY -21.5% QoQ |
| 2024 | 20 -74.4% YoY -60.8% QoQ | - | - | - |
The average 5 years interest of Actinium Pharmaceuticals stock was 8.56 per week. The last year interest of Actinium Pharmaceuticals stock compared to the last 5 years has changed by -57.13%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -53.25%.
After 39 days of this quarter the interest is at 12.0. Based on that we can calculate that during remaining 52 days it will total up to 28.0. Actinium Pharmaceuticals -stock -company expected interest is significantly lower compared to previous quarter (-67.1%) and same quarter last year (-84.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 123 | 146 18.7% QoQ | 100 -31.5% QoQ | 227 127.0% QoQ |
| 2020 | 199 61.8% YoY -12.3% QoQ | 410 180.8% YoY 106.0% QoQ | 540 440.0% YoY 31.7% QoQ | 140 -38.3% YoY -74.1% QoQ |
| 2021 | 19 -90.5% YoY -86.4% QoQ | 174 -57.6% YoY 815.8% QoQ | 69 -87.2% YoY -60.3% QoQ | 70 -50.0% YoY 1.4% QoQ |
| 2022 | 109 473.7% YoY 55.7% QoQ | 113 -35.1% YoY 3.7% QoQ | 101 46.4% YoY -10.6% QoQ | 90 28.6% YoY -10.9% QoQ |
| 2023 | 183 67.9% YoY 103.3% QoQ | 160 41.6% YoY -12.6% QoQ | 143 41.6% YoY -10.6% QoQ | 85 -5.6% YoY -40.6% QoQ |
| 2024 | 12 -93.4% YoY -85.9% QoQ | - | - | - |
The average 5 years interest of Actinium Pharmaceuticals -stock -company was 12.31 per week. The last year interest of Actinium Pharmaceuticals -stock -company compared to the last 5 years has changed by -19.42%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -23.46%.
There is not enough data for Actinium Pharmaceuticals reviews to provide analysis
There is not enough data for Actinium Pharmaceuticals reviews to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals reviews to provide analysis
There is not enough data for Actinium Pharmaceuticals CAR T-cell therapy to provide analysis
There is not enough data for Actinium Pharmaceuticals CAR T-cell therapy to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals CAR T-cell therapy to provide analysis
There is not enough data for Actinium Pharmaceuticals CD33 to provide analysis
There is not enough data for Actinium Pharmaceuticals CD33 to provide correlation calculation
There is not enough data for Actinium Pharmaceuticals CD33 to provide analysis